Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.
D000777:Anesthetics / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004336:Drug Antagonism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008774:Methylphenidate / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D006899:Mixed Function Oxygenases / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism; D009020:Morphine / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology*; D010622:Phencyclidine / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism*; D010862:Pilocarpine / Q000494:pharmacology*; D011339:Probenecid / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology*; D014043:Tolazoline / Q000494:pharmacology*; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014443:Tyrosine / Q000494:pharmacology; D015049:Zoxazolamine / Q000494:pharmacology*
D000777:Anesthetics; D008781:Methyltyrosines; D010276:Parasympatholytics; D010277:Parasympathomimetics; D010648:Phenylacetates; D014149:Tranquilizing Agents; D010862:Pilocarpine; D008774:Methylphenidate; D014443:Tyrosine; D006897:Hydroxyindoleacetic Acid; D009020:Morphine; D012110:Reserpine; D015049:Zoxazolamine; D010293:Pargyline; D014043:Tolazoline; D006899:Mixed Function Oxygenases; D008995:Monoamine Oxidase; D010622:Phencyclidine; D007099:Imipramine; D011339:Probenecid; D004298:Dopamine